FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

A-S Medication Solutions Valsartan and Hydrochlorothiazide Tablets Recall

Valsartan and Hydrochlorothiazide Tablets, Valsartan 320 MG and Hydrochlorothiazide 25…

A-S Medication Solutions LLC. · Libertyville, IL

Risk level
Class II
Reported by FDA
Aug 29, 2018
Recall ID
D-1111-2018
Check your lot numberHow we source this data

Summary

A-S Medication Solutions recalled Valsartan and Hydrochlorothiazide Tablets starting Jul 17, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1111-2018 on Aug 29, 2018. Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product. Status: Ongoing.

Why it was recalled

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Product description

Valsartan and Hydrochlorothiazide Tablets, Valsartan 320 MG and Hydrochlorothiazide 25 MG, 90 tablets per bottle, Rx Only, MFG: Arrow Pharm (Malta) LTD, Birzebbugia, BBG 3000 Malta. NDC: 54569-6488-0

Lot numbers, UPCs & expiration codes

Expiry, lot: 1/31/2019: 7293219; 6/30/2019: 7362231, 8074161, 8110184, 8197215, 8114178, 8115123; 9/30/2018: 7132187, 7160161, 7180150, 7268239

Where it was sold

Nationwide USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1111-2018
Classification
Class II
Status
Ongoing
Recall initiated
Jul 17, 2018
FDA report date
Aug 29, 2018
Quantity
531 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
A-S Medication Solutions LLC.

Original FDA data

Every field from FDA enforcement report D-1111-2018, exactly as published.

Show all FDA fields
City
Libertyville
State
IL
Status
Ongoing
Country
United States
Event ID
80748
Address
2401 Commerce Dr
Code information
Expiry, lot: 1/31/2019: 7293219; 6/30/2019: 7362231, 8074161, 8110184, 8197215, 8114178, 8115123; 9/30/2018: 7132187, 7160161, 7180150, 7268239
Postal code
60048-4464
Report date
Aug 29, 2018
Product type
Drugs
Recall number
D-1111-2018
Classification
Class II
Recalling firm
A-S Medication Solutions LLC.
Product quantity
531 bottles
Reason for recall
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Valsartan and Hydrochlorothiazide Tablets, Valsartan 320 MG and Hydrochlorothiazide 25 MG, 90 tablets per bottle, Rx Only, MFG: Arrow Pharm (Malta) LTD, Birzebbugia, BBG 3000 Malta. NDC: 54569-6488-0
Distribution pattern
Nationwide USA
Recall initiation date
Jul 17, 2018
Initial firm notification
Letter
Center classification date
Aug 18, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1111-2018, published Aug 29, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls